Introduction
As of January 1, 2008, the French National Institute for Statistics and Economic Studies estimated that the French population over age 80 years was about three millions, and their expected longevity was 8 years for men and 9 years for women. Thus, more and more octogenarians may undergo total hip arthroplasty (THA) for the treatment of osteoarthritis in coming years, especially since the noticeable decrease in operative mortality [1] is leading to increasingly rare anaesthetic contraindications. Although the benefits, particularly in pain relief, from these interventions do not need to be demonstrated any more, numerous studies [2] [3] [4] [5] [6] [7] [8] [9] [10] have reported significant postoperative medico-surgical complications not systematically predictable by preanaesthesia consultation. Thus, evaluation of the postoperative risks, and the consequences of associated orthopaedic or non-orthopaedic pathologies, on the functional outcome of operated patients is assuming increasing significance in surgical decision-making. As most series on hip prosthesis in patients over age 80 years date back to pre-1990, it appeared interesting to us to review our recent experience by:
• describing complications in a population of octogenarians with total prosthesis for the treatment of osteoarthritis by applying modern anaesthesia-resuscitation protocols; • determining if the risk factors of complications and of the functional prognosis could be identified, to help in surgical decision-making; • improving the quality of patient data on potential risks and targeted functional outcomes.
Patients and methods
Among 723 primary hip prostheses implanted in our institution between October 2003 and December 2006, 75 were received by 72 patients aged 80 years and more and who were the subject of retrospective analysis. Twenty-six of them were men, and 46 women. Two women and one man underwent bilateral interventions. Average age was 82 years (minimum 80, maximum 93 years). The general state of these patients was evaluated according to the score of the American Society of Anesthesiology (ASA). Twenty-seven patients were scored as ASA 2, and 45 as ASA 3. None had ASA scores of 1 or 4. The functional score of these patients was evaluated preoperatively according to the classification of Charnley [11] , which counted associated orthopaedic pathologies as well as general pathologies that could affect deambulation. Fifty patients were class A, six class B, and 16 class C. The body mass index (BMI, weight/height 2 ) of each patient was measured according to World Health Organization criteria. Average BMI was 25.3, with a minimum of 17.7 and a maximum of 33.8. Thirty-six patients were considered to be normal, 27 were overweight, and nine had average obesity. Sixty-two patients manifested 1 or more co-morbidities ( Table 1) . Twenty-seven patients had one co-morbidity, 17 had two, and 18 had three or more.
Before all interventions, and with the usual anaesthetic evaluation, all patients underwent dental and urinary profiling to detect infectious sources that were eradicated systematically.
All patients received a cemented femoral implant (Sapia®, Tornier, Saint-Ismier, France), a 28-mm stainless steel ball and cemented, retentive acetabular component. Palacos cement, with Gentamycin TM (Schering Plough, Brussels, Belgium) added, was introduced by syringe in the femoral canal after obstruction with a polyethylene obturator (Tornier, Saint-Ismier, France).
Antibioprophylaxis with first-generation cephalosporine was used for 24 hours. Thromboembolic accidents were prevented with low-molecular weight heparins for 1 month in association with compression stockings. Doppler control was established postoperatively in a systematic manner, to find thromboembolic complications [12] . Because of patient age in this series, prophylaxis against periarticular ossification by anti-inflammatory agents was never instituted. Walking with support was authorized the day after the intervention, except when associated acetabular autograft (5 cases) were performed which delayed walking by 1 month.
Patients were reviewed at 3 months postoperatively, then every year, and evaluated according to the criteria of Merle 
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Complications
No patient died immediately after or during the intervention. Nineteen patients presented 27 complications ( Table 2 ). Four patients had major complications, and 15 had 23 minor complications. Complications occurred in nine patients rated ASA 3 and 10 in rated ASA 2, but without any statistically significant difference (p > 0.1). Co-morbidities never influenced the occurrence of complications whether they were minor or major (p > 0.5). Two patients (2.6%) had a late isolated dislocation (9 and 18 months after the intervention) while washing their feet. Tomodensitometric and radiological measurements for implant positioning revealed acetabular anteversion to 17 • and 10 • , and femoral anteversion to 12 and 7 • , respectively. Acetabular inclination was 40 • and 47 • . The dislocations were reduced by external maneuvers, without the need for additional surgery. No infection, either superficial or profound, was encountered.
Twenty-eight patients were transfused with 63 bags totally. While anticoagulant or antiaggregant administration did not appear to be a risk factor of bleeding (p > 0.5), BMI less than 25 was found to be a significant risk factor (p ≈ 0.01) ( Table 3) .
Clinical results
Average follow-up was 31 months (minimum 5, maximum 54 months). No patient was lost to follow-up. Two patients died, at 5 and 36 months respectively, with no connection to the intervention. No prosthetic revision, whatever the cause, was foreseen or took place. At maximum followup, 48 patients were reviewed on consultation for clinical and radiographic evaluation. Twenty-two patients were contacted by telephone and responded to a questionnaire.
Average duration of hospitalization was 10.3 days (minimum 7, maximum 14 days). Seventeen patients were pain-free and walked without restriction. Thirty-six patients scored between 15 and 17; of them, 27 complained of transient pains-in association with the use of a cane ''for safety'' purposes when going out for 12 of them. Among these patients, five had an excellent clinical evaluation of their hip but were limited, by arteritis in one case, by cardiopathy in two others, by a narrow lumbar canal in the fourth case, and by chronic respiratory insufficiency in the fifth patient.
Nineteen patients had a Merle d'Aubigné score under 15. All were satisfied with their intervention and did not have or had very little pain. Two patients aged over 85 years used a cane permanently and did not walk for more than 15 minutes outside their residence. One patient of 95 years did not ever leave his home.
Eleven were limited by an associated orthopaedic pathology (6 contralateral hip osteoarthritis, 1 loosening of a contralateral THA, 3 arthroses of the knee, 1 non union of a femoral neck fracture), which reduced the walk perimeter and required the permanent use of two canes.
Five were limited by medical problems (2 cases of evolving Parkinson disease, 1 balance problem, 1 major cardiac insufficiency, 1 lung cancer). Patients transfused/total number 14/28 14/57 p = 0.03 Whereas preoperative ASA score did not allow us to evaluate the consequences of a precarious general state on the quality of the functional results of a THA (p > 0.5), the occurrence of an associated orthopaedic pathology strongly conditioned the quality of the intervention (Table 4 ) (p < 0.001). More generally, Charnley's classification appeared to be the most relevant. The functional results in class A patients, according to the Postel-Merle d'Aubigné hip scoring system, were statistically greater than those of class B (p < 0.001) or C (p < 0.001) ( Table 5 ).
Discussion
The frequency of complications occurring after THA in patients over age 80 years varies from 24% [8] to 42.5% [14] compared to the rate of about 8% for the general population [15] [16] [17] . If, however, aseptic unsealing and wear are the main causes of revision in patients of all ages, the problems remain secondary in patients over age 80 years [18] as long as a cement or hybrid implant is used (cement femur, cementless cup). Perioperative mortality in patients older than 80 years, although 10 times lower in 1999 than in 1978 [10] , remained significant between 0.4% [17] and 3.7% [19] . We did not observe any perioperative deaths, despite the usual level of co-morbidities [6, 8, 10] , but the size of our series did not allow us to draw any definitive conclusion.
The main causes of THA revision in patients over age 80 years are, according to the Finnish Registry [18] , infections or dislocations. No deep or superficial infection was recorded in our study, although the rate could reach 7.5% [3] . Newington et al. [2] have demonstrated the deleterious effect of a dislocation and its possible ''snowball effect''. Even if the dislocation level in our series remains modest [2.6%] and no patient had a recurrence, the use of a retentive acetabular component and an anterior approach known to be less ''dislocating'' [20] [21] [22] does not prevent their occurrence and requires, importantly, that we pay attention to postoperative patient education. In fact, no explanation for these dislocations has been found, except that they are produced during flexion-internal rotation movements that should be avoided. Finally, unlike the dislocations observed with double mobility cups [23, 24] , the current were always reduced by external maneuvers.
In the framework of surgery for the treatment of hip osteoarthritis, we have not found evidence correlating the occurrence of perioperative complications and ASA score or co-morbidities. Our series was too limited to arrive at a definitive conclusion, but was in concurrence with the findings of Perka et al. [25] in more than 600 interventions. Only BMI less than 25 has to be apparently taken into account for an eventual perioperative transfusion.
If the effect of THA on pain does not need to be demonstrated any longer, the global functional score of Merle d'Aubigné remains irregular in our experience and varies from 10 to 18 in function, notably with associated orthopaedic or general pathologies. Charnley's score seems to be particularly relevant in foreseeing the functional outcome of hip arthroplasty in patients older than 80 years and informing them about the autonomy that they may likely recover.
Conclusions
Our experience shows that even if the level of complications after THA in patients over the age of 80 years is more significant than for unselected patients, it does not raise doubt about the quality of the functional results. We were unable to highlight the risk factors of these complications. However, our study demonstrates the close relationship between the global functional score and of associated pathologies. In this framework, Charnley's classification is very interesting in deciding an intervention and informing patients of their possible outcome.
